BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2413340)

  • 1. Chemotherapy-associated Raynaud's phenomenon in a two-year-old girl.
    McGuire WA; Passo MH; Weetman RM
    Med Pediatr Oncol; 1985; 13(6):392-4. PubMed ID: 2413340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endodermal sinus tumor of the infant vagina treated exclusively by chemotherapy.
    Collins HS; Burke TW; Heller PB; Olson TA; Woodward JE; Park RC
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):507-9. PubMed ID: 2464779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovary.
    Davis TE; Loprinzi CL; Buchler DA
    Gynecol Oncol; 1984 Sep; 19(1):46-52. PubMed ID: 6205945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
    Vogelzang NJ; Torkelson JL; Kennedy BJ
    Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
    Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
    Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Raynaud's phenomenon following combined cytostatic treatment of malignant testicular tumours].
    Scheulen ME; Schmidt CG
    Dtsch Med Wochenschr; 1982 Oct; 107(43):1640-4. PubMed ID: 6183087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
    Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
    Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma.
    Reiser M; Bruns C; Hartmann P; Salzberger B; Diehl V; Fätkenheuer G
    Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):58-60. PubMed ID: 9512187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Raynaud's disease after treatment with bleomycin and vinblastine].
    Dzieza-Lalowicz I; Mykała-Cieśla J
    Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
    [No Abstract]   [Full Text] [Related]  

  • 10. [VAB-3 chemotherapy of endodermal sinus tumor of the ovary].
    Goto Y; Imai K; Yamashita M; Konishi I; Fujii S; Noda Y; Okamura H; Mori T; Suzuki A
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):75-80. PubMed ID: 2440967
    [No Abstract]   [Full Text] [Related]  

  • 11. [Raynaud's phenomenon and finger necrosis after treatment of ovarian seminoma with bleomycin, vinblastine and 5-fluorouracil].
    Werquin S; Kacet S; Caron J; Lacroix D; Libersa C; Coget JM; Lekieffre J
    Ann Cardiol Angeiol (Paris); 1987 Oct; 36(8):409-12. PubMed ID: 2445238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
    Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
    Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin.
    von Gunten CF; Roth EL; Von Roenn JH
    Cancer; 1993 Sep; 72(6):2004-6. PubMed ID: 7689922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
    Dunlop PR; Hendy-Ibbs PM
    Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary.
    Sessa C; Bonazzi C; Landoni F; Pecorelli S; Sartori E; Mangioni C
    Obstet Gynecol; 1987 Aug; 70(2):220-4. PubMed ID: 2439966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's phenomenon in a child with medulloblastoma as a late effect of chemotherapy.
    Atas E; Korkmazer N; Artik HA; Babacan O; Kesik V
    J Cancer Res Ther; 2015; 11(3):666. PubMed ID: 26458705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raynaud's phenomenon following cytotoxic chemotherapy successfully managed by dorsal sympathectomy.
    MacLeod PM; Tyrrell CJ; Bliss B
    Eur J Surg Oncol; 1989 Feb; 15(1):79-81. PubMed ID: 2465189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin.
    Hansen SW; Olsen N; Rossing N; Rørth M
    Ann Oncol; 1990 Jul; 1(4):289-92. PubMed ID: 1702313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin-induced Raynaud's phenomenon after single-dose exposure: risk factors and treatment with intravenous iloprost infusion.
    McGrath SE; Webb A; Walker-Bone K
    J Clin Oncol; 2013 Feb; 31(4):e51-2. PubMed ID: 23270004
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy following treatment of endodermal sinus tumor of the ovary with combination chemotherapy, including cis-platinum.
    Curtin JP; Adcock LL
    Gynecol Oncol; 1986 Jun; 24(2):268-70. PubMed ID: 2423419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.